Bayer issues consensus statement on sustainable LARC provision in primary care

Bayer has issued a ‘Sustainable and Fair Fitting Fee' consensus statement that calls on the UK Government to take action to tackle inequalities in women’s access to long-acting reversible contraception (LARC).

Titled ‘Harnessing the potential of long-acting reversible contraception (LARC) to improve public health, generate savings, and cut waiting lists: a consensus statement’, it has been endorsed by 14 organisations and individual experts in Women’s Health and reproductive healthcare, including the Faculty of Sexual and Reproductive Healthcare (FSRH), Royal College of Obstetricians and Gynaecologist (RCOG) and the All Party Parliamentary Group on Sexual and Reproductive Health (APPG on SRH). 

The community-backed consensus statement identifies the current issues in primary care LARC access. LARC methods, including contraceptive implant, intrauterine device (IUD), intrauterine system (IUS), and contraceptive injection1, are highly clinically and cost-effective forms of contraception2 and have a key role in supporting women’s reproductive health. However, many women in the UK currently face a stark postcode lottery in access to different types of LARC methods – consequently, women in the most deprived areas of England are more than twice as likely to have an abortion as those in the least3, generating health inequalities with far-reaching impacts across women, their families, and the NHS. 

While Government analysis has illustrated significant savings to the NHS through improved provision: every £1 invested in the provision of LARC in primary care saves £48 in healthcare and non-healthcare costs over 10 years,2 this return on investment is currently underpowered. Fragmented commissioning arrangements and variation in fitting fees are the two main reasons for disabling many general practices or community services to provide LARCs for contraception and gynaecological purposes.4


Issued on the heels of the Government’s new priorities in Women’s Health for 2024, of which a key area is the rollout of Women’s Health Hubs in every Integrated Care System (ICS), the consensus statement sets out a suggested policy framework. It calls on the Government to ask all ICSs to jointly commission integrated LARC pathways – underpinned by a nationally-set, minimum fee for LARC in primary care via Women’s Health Hubs. The framework has been developed in consultation with expert stakeholders and specifies the principles to support sustainable LARC services in a cost-effective way, to help systems benefit on return-on-investment in LARC. 

Ursula Montgomery, Head of Healthcare Policy and Partnerships, Bayer UK, comments:


“With a key role in supporting women’s reproductive health, access to LARC is an important public health issue. We are very pleased that so many women’s health leaders have endorsed the statement. Together, we wish to work in partnership with Government to deliver this recommendation for fair and sustainable LARC provision as it develops further guidance for local areas on Women’s Health Hubs and look forward to continuing to play a role in this important discussion.”

Click here to download the full consensus statement

Full list of organisations and experts endorsing the consensus statement: 


  1. The Faculty of Sexual and Reproductive Healthcare (FSRH)
  2. Royal College of Obstetricians and Gynaecologists (RCOG)
  3. Primary Care Women’s Health Forum (PCWHF)
  4. English HIV and Sexual Health Commissioners Group 
  5. Royal College of Nursing (RCN)
  6. Drs for Choices UK
  7. All Party Parliamentary Group on Sexual and Reproductive Health (APPG on SRH)
  8. Faculty of Public Health
  9. Wellbeing of Women
  10. MSI Reproductive Choices UK



  1. Dr Stephanie Cook, Clinical Lead for Liverpool Women’s Health Hubs
  2. Richard Scarborough, former Commissioning Manager for Sexual Health, Manchester City Council
  3. Dr Amanda Britton, Hampshire
  4. Tracey Elliott, Advanced Nurse Practitioner and Lead Nurse, Primary Care Women’s Health Forum



  1. Long-lasting reversible contraception. Sexwise. Available at: 

  2. Public Health England, Health England, Extending Public Health England’s contraception return on investment tool, Maternity and primary care settings, July 2021

  3. Office for Health Improvement and Disparities, Abortion statistics, England and Wales: 2021, last updated May 2023 

  4. Primary Care Women’s Health Forum, On the brink: The reality of Long-Acting Reversible Contraception (LARC) provision in primary care, June 2023